Barclays’s VivoSim Labs VIVS Stock Holding History

Barclays’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-58	Closed	-$47K	–	7029
2016 Q4	$47K	Buy	+58	New	+$46K	﹤0.01%	5210

Other funds holding VIVS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Barclays's VIVS Position: Q4 2019 in Review

Barclays held its VivoSim Labs (VIVS) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6892.

Barclays first reported a position in VIVS in Q3 2013 and has held it in 21 quarters since. The position peaked at $357K in Q4 2013. 78 funds tracked by Wall St. Rank hold VIVS as of Q4 2019.

Barclays held 0 shares of VivoSim Labs worth $0 as of Q4 2019.
Barclays left its VivoSim Labs share count unchanged in Q4 2019.
VivoSim Labs made up ﹤0.01% of Barclays's portfolio in Q4 2019, its #6892 holding.
Barclays first reported a position in VivoSim Labs in Q3 2013 and has held it in 21 quarters since.
Barclays's VivoSim Labs position peaked at $357K in Q4 2013.
78 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2019.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.